HER2(ヒト上皮成長因子受容体2)阻害剤世界市場の発展状況と動向 2024-2030
英文タイトル: Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書はHER2(ヒト上皮成長因子受容体2)阻害剤市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはHER2(ヒト上皮成長因子受容体2)阻害剤の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界のHER2(ヒト上皮成長因子受容体2)阻害剤市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはHER2(ヒト上皮成長因子受容体2)阻害剤のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にHER2(ヒト上皮成長因子受容体2)阻害剤市場を分類しています。本研究に含まれる主な企業は:F. Hoffmann-La Roche Ltd、Merck & Co., Inc、Novartis AG、Pfizer Inc、Puma Biotechnology, Inc
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Monotherapy
Combination Therapy
用途別の市場セグメント:
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
本レポートの詳細内容
世界のHER2(ヒト上皮成長因子受容体2)阻害剤市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、HER2(ヒト上皮成長因子受容体2)阻害剤タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のHER2(ヒト上皮成長因子受容体2)阻害剤収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のHER2(ヒト上皮成長因子受容体2)阻害剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、HER2(ヒト上皮成長因子受容体2)阻害剤市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
HER2(ヒト上皮成長因子受容体2)阻害剤のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:HER2(ヒト上皮成長因子受容体2)阻害剤のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:HER2(ヒト上皮成長因子受容体2)阻害剤の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章HER2(ヒト上皮成長因子受容体2)阻害剤企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:HER2(ヒト上皮成長因子受容体2)阻害剤の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:HER2(ヒト上皮成長因子受容体2)阻害剤の主要企業の概要を提供し、製品の説明と仕様、HER2(ヒト上皮成長因子受容体2)阻害剤の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors Market Analysis and Insights: Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market The global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The Europe market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The global key companies of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc and Puma Biotechnology, Inc, etc. In 2023, the global top five players had a share approximately % in terms of revenue. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is widely used in various fields, such as Breast Cancer, Gastric Cancer, Ovarian Cancer and Others, etc. Breast Cancer provides greatest supports to the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors industry development. In 2023, global % revenue of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors went into Breast Cancer filed and the proportion will reach to % in 2030. Report Covers: This report presents an overview of global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc and Puma Biotechnology, Inc, etc. Market Segmentation By Company F. Hoffmann-La Roche Ltd Merck & Co., Inc Novartis AG Pfizer Inc Puma Biotechnology, Inc Segment by Type Monotherapy Combination Therapy Segment by Application Breast Cancer Gastric Cancer Ovarian Cancer Others By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Gastric Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2019-2030)
2.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Region
2.2.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Dynamics
2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Trends
2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors by Players
3.1.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2019-2024)
3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio
3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2023
3.5 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Head office and Area Served
3.6 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application
3.7 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type
4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2025-2030)
5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application
5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2019-2030)
6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
6.2.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024)
6.2.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030)
6.2.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030)
6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
6.3.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024)
6.3.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030)
6.3.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030)
6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
6.4.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024)
6.4.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2019-2030)
7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
7.2.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024)
7.2.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030)
7.2.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030)
7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
7.3.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024)
7.3.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030)
7.3.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030)
7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
7.4.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024)
7.4.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2019-2030)
8.2 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
8.2.1 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024)
8.2.2 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030)
8.2.3 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030)
8.3 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
8.3.1 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024)
8.3.2 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030)
8.3.3 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2019-2030)
9.2 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
9.2.1 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024)
9.2.2 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030)
9.2.3 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030)
9.3 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
9.3.1 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024)
9.3.2 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030)
9.3.3 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030)
9.4 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region
9.4.1 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2019-2024)
9.4.3 Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Ltd Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024)
11.2.5 Merck & Co., Inc Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024)
11.3.5 Novartis AG Recent Developments
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Pfizer Inc Business Overview
11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024)
11.4.5 Pfizer Inc Recent Developments
11.5 Puma Biotechnology, Inc
11.5.1 Puma Biotechnology, Inc Company Details
11.5.2 Puma Biotechnology, Inc Business Overview
11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024)
11.5.5 Puma Biotechnology, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2019-2024) & (US$ Million) Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2019-2024) Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2025-2030) Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2019-2024) & (US$ Million) Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Share by Players (2019-2024) Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2023) Table 17. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Headquarters and Area Served Table 20. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application Table 21. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2019-2024) Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2025-2030) Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Share by Application (2019-2024) Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Share by Application (2025-2030) Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030) & (US$ Million) Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 34. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030) & (US$ Million) Table 35. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024) & (US$ Million) Table 37. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030) & (US$ Million) Table 45. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 46. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030) & (US$ Million) Table 47. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 48. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2025-2030) & (US$ Million) Table 63. F. Hoffmann-La Roche Ltd Company Details Table 64. F. Hoffmann-La Roche Ltd Business Overview Table 65. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 66. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) & (US$ Million) Table 67. F. Hoffmann-La Roche Ltd Recent Developments Table 68. Merck & Co., Inc Company Details Table 69. Merck & Co., Inc Business Overview Table 70. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 71. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) & (US$ Million) Table 72. Merck & Co., Inc Recent Developments Table 73. Novartis AG Company Details Table 74. Novartis AG Business Overview Table 75. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 76. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) & (US$ Million) Table 77. Novartis AG Recent Developments Table 78. Pfizer Inc Company Details Table 79. Pfizer Inc Business Overview Table 80. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 81. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) & (US$ Million) Table 82. Pfizer Inc Recent Developments Table 83. Puma Biotechnology, Inc Company Details Table 84. Puma Biotechnology, Inc Business Overview Table 85. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 86. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) & (US$ Million) Table 87. Puma Biotechnology, Inc Recent Developments Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2023 VS 2030 Figure 3. Monotherapy Features Figure 4. Combination Therapy Features Figure 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2023 VS 2030 Figure 7. Breast Cancer Case Studies Figure 8. Gastric Cancer Case Studies Figure 9. Ovarian Cancer Case Studies Figure 10. Others Case Studies Figure 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered Figure 12. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region: 2023 VS 2030 Figure 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2023 Figure 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2023) Figure 17. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2023 Figure 18. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030) Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030) Figure 21. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2019-2030) Figure 22. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 24. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY (2019-2030) & (US$ Million) Figure 25. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030) Figure 26. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030) Figure 27. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2019-2030) Figure 28. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Nordic Countries HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY (2019-2030) & (US$ Million) Figure 35. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030) Figure 36. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030) Figure 37. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY (2019-2030) & (US$ Million) Figure 38. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030) Figure 39. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030) Figure 40. Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2019-2030) Figure 41. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. China Taiwan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY (2019-2030) & (US$ Million) Figure 48. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2019-2030) Figure 49. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2019-2030) Figure 50. Middle East, Africa, and Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2019-2030) Figure 51. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Israel HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. GCC Countries HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) Figure 58. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) Figure 59. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) Figure 60. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) Figure 61. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2019-2024) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)